Methods (1) Purification and identification of CAFs. CAFs and normal fibroblasts (NFs) were prospectively obtained from the cancer tissue and normal breast tissue of six patients with TNBC at stage Ⅱ or Ⅲ, who were treated in Zhujiang Hospital of Southern Medical University from January 2015 to December 2016.α-smooth muscle actin (α-SMA) was labeled by fluorescent antibody and the proportion of α-SMA positive cells was calculated. The expression of α-SMA in CAFs and NFs was determined by Western blot, respectively, to identify CAFs used for this experiment. (2) Evaluation of CAFs autophagy. Autophagic biomarkers beclin 1 and p62 were measured by Western blot in CAFs group, NFs group and CAFs group pretreated with 3-methyladenine (CAFs+ 3-MA group), respectively. (3) Identifying the migration of MDA-MB-231 and BT-549 cells caused by CAFs autophagy. The migration of MDA-MB-231 or BT-549 cells was detected by the Transwell chamber under different conditions (medium/NFs/CAFs/CAFs+ 3-MA). (4) Clarifying the effect of CAFs autophagy on epithelial-mesenchymal transition (EMT) in MDA-MB-231 or BT-549 cells. The EMT-related proteins E-cadherin, N-cadherin and vimentin were detected by Western blot in MDA-MB-231 or BT-549 cells cultured in different conditions (medium, CAFs-CM or CAFs+ 3-MA-CM). The data of normal distribution were expressed by ±s and the data of skewed distribution were expressed by M(P25-P75). Nonparametric rank-sum test of two independent samples was used to compare α-SMA expression, t test of two independent samples was used to compare the percentage of α-SMA-positive cells, and single-factor analysis of variance was used to compare the autophagic protein expression, cell migration rate and EMT-related protein expression among groups.
Results (1) α-SMA-positive cells were observed under a fluorescence microscope. The result showed that the percentage of α-SMA-positive cells in CAFs was significantly higher than that in NFs [(81.11±3.95)% vs(5.11±2.37)%, t=49.49, P<0.001)]. Western blot analysis indicated that the expression of α-SMA in CAFs and NFs was 0.98(0.95-0.98) and 0.48 (0.47-0.48), respectively, suggesting a significant difference (Z=2.023, P=0.043). (2) The expression of beclin 1 was 0.99±0.03, 0.73±0.04 and 0.26±0.02 in CAFs group, NFs group and CAFs+ 3-MA group, respectively, indicating a significant difference (F=546.188, P<0.001). The expression of beclin 1 in CAFs group was significantly higher than that in CAFs+ 3-MA group (P<0.001). The expression of p62 was 0.75±0.02, 0.98±0.03 and 0.97±0.01 in CAFs group, NFs group and CAFs+ 3-MA group, respectively, indicating a significant difference (F=136.353, P<0.001). The expression of p62 expression in CAFs group was significantly lower than that in CAFs+ 3-MA group(P<0.001). (3)The number of migrated MDA-MB-231 cells was 41.67±2.78, 23.33±2.18, 22.00±1.76 and 18.00±2.12 in CAFs group, NFs group, CAFs+ 3-MA group and medium group, respectively, indicating a significant difference(F=198.374, P<0.001). The number of migrated BT-549 cells was 35.22±1.97, 22.00±2.60, 25.11±2.15 and 15.22±2.00 in CAFs group, NFs group, CAFs+ 3-MA group and medium group, respectively, indicating a significant difference(F=129.424, P<0.001). The number of migrated MDA-MB-231 or BT-549 cells in CAFs group was significantly higher than that in other three groups (P<0.050). (4) When MDA-MB-231 cells were cultured in medium, CAFs-CM or CAFs+ 3-MA-CM, Western blot analysis showed that E-cadherin expression was 0.79±0.03, 0.54±0.02 and 0.87±0.04 in 3 groups, respectively, indicating a significant difference(F=139.286, P<0.001); N-cadherin expression was 0.59±0.02, 1.00±0.02 and 0.93±0.02 in 3 groups, respectively, indicating a significant difference(F=604.905, P<0.001); vimentin expression was 0.62±0.03, 1.01±0.01 and 0.89±0.09 in 3 groups, respectively, indicating a significant difference(F=43.884, P<0.001). When BT-549 cells was cultured in medium, CAFs-CM and CAFs+ 3-MA-CM, E-cadherin expression was 1.01±0.03, 0.63±0.03 and 0.98±0.03 in 3 groups, respectively, indicating a significant difference(F=210.102, P<0.001); N-cadherin expression was 0.58±0.01, 0.94±0.04 and 0.95±0.03 in 3 groups, respectively, indicating a significant difference(F=184.477, P<0.001), vimentin expression was 0.61±0.01, 0.98±0.03 and 0.75±0.02 in 3 groups, respectively, indicating a significant difference(F=217.659, P<0.001).